Cyclo Therapeutics (CYTH) Competitor Comparison
We are evaluating the key criteria listed to compare Cyclo Therapeutics (CYTH) against its competitors in the Biotechnology industry.
Market Capitalization
296 / 368Gross Profits
127 / 278Total Revenue
238 / 300EBITDA
80 / 337Free Cashflow
78 / 352Quick Ratio
348 / 357Earnings per Share
109 / 359Dividend yield
0 / 6Total Cash
347 / 358Performance 3 years
305 / 368Performance 5 years
336 / 368Performance 10 years
333 / 368Linearity 3 years
263 / 368Linearity 5 years
257 / 368Linearity 10 years
208 / 366Total Rank
101 / 368Dividend Rank
102 / 368Valuation Rank
201 / 368Piotroski Rank
272 / 368Muliplier Rank
23 / 368Performance 3 years - CYTH ranking 305 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.